Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of human insulin in pens. People living with type 1 diabetes who are […]
http://dlvr.it/TFgBn5
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
More from Latest StoryMore posts in Latest Story »
- No title
- Polly Inglis earns maiden NZ call-up, Lauren Down returns for India ODIs
- Mitchell: ‘We can’t change the wicket, but we’ll find a way to adapt’
- Nigel Slater’s recipes for sea bass with beans and tarragon, and pistachio tarts with blackberries
- Polly Inglis earns maiden NZ call-up, Lauren Down returns for India ODIs
Be First to Comment